Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Paul Bunn to Mycosis Fungoides

This is a "connection" page, showing publications Paul Bunn has written about Mycosis Fungoides.

 
Connection Strength
 
 
 
1.023
 
  1. Bunn PA, Foss FM. T-cell lymphoma cell lines (HUT102 and HUT78) established at the National Cancer Institute: history and importance to understanding the biology, clinical features, and therapy of cutaneous T-cell lymphomas (CTCL) and adult T-cell leukemia-lymphomas (ATLL). J Cell Biochem Suppl. 1996; 24:12-23.
    View in: PubMed
    Score: 0.127
  2. Kemme DJ, Bunn PA. State of the art therapy of mycosis fungoides and S?zary syndrome. Oncology (Williston Park). 1992 Feb; 6(2):31-42; discussion 44, 47-8.
    View in: PubMed
    Score: 0.097
  3. Foon KA, Bunn PA. Alpha-interferon treatment of cutaneous T cell lymphoma and chronic lymphocytic leukemia. Semin Oncol. 1986 Dec; 13(4 Suppl 5):35-9.
    View in: PubMed
    Score: 0.068
  4. Sausville EA, Worsham GF, Matthews MJ, Makuch RW, Fischmann AB, Schechter GP, Gazdar AF, Bunn PA. Histologic assessment of lymph nodes in mycosis fungoides/S?zary syndrome (cutaneous T-cell lymphoma): clinical correlations and prognostic import of a new classification system. Hum Pathol. 1985 Nov; 16(11):1098-109.
    View in: PubMed
    Score: 0.063
  5. Haynes BF, Metzgar RS, Minna JD, Bunn PA. Phenotypic characterization of cutaneous T-cell lymphoma. Use of monoclonal antibodies to compare with other malignant T cells. N Engl J Med. 1981 May 28; 304(22):1319-23.
    View in: PubMed
    Score: 0.046
  6. Bunn PA, Whang-Peng J, Carney DN, Schlam ML, Knutsen T, Gazdar AF. DNA content analysis by flow cytometry and cytogenetic analysis in mycosis fungoides and S?zary syndrome. J Clin Invest. 1980 Jun; 65(6):1440-8.
    View in: PubMed
    Score: 0.043
  7. Lamberg SI, Bunn PA. Cutaneous T-cell lymphomas. Summary of the Mycosis Fungoides Cooperative Group-National Cancer Institute Workshop. Arch Dermatol. 1979 Sep; 115(9):1103-5.
    View in: PubMed
    Score: 0.041
  8. Bunn PA, Fischmann AB, Schechter GP, Kumar PP, Ihde DC, Cohen MH, Fossieck BE, Gazdar AF, Matthews MJ, Eddy JL, Minna JD. Combined modality therapy with electron-beam irradiation and systemic chemotherapy for cutaneous T-cell lymphomas. Cancer Treat Rep. 1979 Apr; 63(4):713-7.
    View in: PubMed
    Score: 0.040
  9. Gazdar AF, Carney DN, Russell EK, Schechter GP, Bunn PA. In vitro growth of cutaneous T-cell lymphomas. Cancer Treat Rep. 1979 Apr; 63(4):587-90.
    View in: PubMed
    Score: 0.040
  10. Lamberg SI, Bunn PA. Proceedings of the Workshop on Cutaneous T-Cell Lymphomas (Mycosis Fungoides and S?zary Syndrome). Introduction. Cancer Treat Rep. 1979 Apr; 63(4):561-4.
    View in: PubMed
    Score: 0.040
  11. Bunn PA, Lamberg SI. Report of the Committee on Staging and Classification of Cutaneous T-Cell Lymphomas. Cancer Treat Rep. 1979 Apr; 63(4):725-8.
    View in: PubMed
    Score: 0.040
  12. Bunn PA. Rational therapy for cutaneous T-cell lymphomas in the 1990s. Fact or fancy? Arch Dermatol. 1995 May; 131(5):603-5.
    View in: PubMed
    Score: 0.030
  13. Bunn PA, Hoffman SJ, Norris D, Golitz LE, Aeling JL. Systemic therapy of cutaneous T-cell lymphomas (mycosis fungoides and the S?zary syndrome). Ann Intern Med. 1994 Oct 15; 121(8):592-602.
    View in: PubMed
    Score: 0.029
  14. Roenigk HH, Kuzel TM, Skoutelis AP, Springer E, Yu G, Caro W, Gilyon K, Variakojis D, Kaul K, Bunn PA, et al. Photochemotherapy alone or combined with interferon alpha-2a in the treatment of cutaneous T-cell lymphoma. J Invest Dermatol. 1990 Dec; 95(6 Suppl):198S-205S.
    View in: PubMed
    Score: 0.022
  15. Kaplan EH, Rosen ST, Norris DB, Roenigk HH, Saks SR, Bunn PA. Phase II study of recombinant human interferon gamma for treatment of cutaneous T-cell lymphoma. J Natl Cancer Inst. 1990 Feb 07; 82(3):208-12.
    View in: PubMed
    Score: 0.021
  16. Kohn EC, Steis RG, Sausville EA, Veach SR, Stocker JL, Phelps R, Franco S, Longo DL, Bunn PA, Ihde DC. Phase II trial of intermittent high-dose recombinant interferon alfa-2a in mycosis fungoides and the S?zary syndrome. J Clin Oncol. 1990 Jan; 8(1):155-60.
    View in: PubMed
    Score: 0.021
  17. Kaye FJ, Bunn PA, Steinberg SM, Stocker JL, Ihde DC, Fischmann AB, Glatstein EJ, Schechter GP, Phelps RM, Foss FM, et al. A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides. N Engl J Med. 1989 Dec 28; 321(26):1784-90.
    View in: PubMed
    Score: 0.021
  18. Dmitrovsky E, Matthews MJ, Bunn PA, Schechter GP, Makuch RW, Winkler CF, Eddy J, Sausville EA, Ihde DC. Cytologic transformation in cutaneous T cell lymphoma: a clinicopathologic entity associated with poor prognosis. J Clin Oncol. 1987 Feb; 5(2):208-15.
    View in: PubMed
    Score: 0.017
  19. Bunn PA, Ihde DC, Foon KA. Recombinant interferon alfa-2a, an active agent in advanced cutaneous T-cell lymphomas. Int J Cancer Suppl. 1987; 1:9-13.
    View in: PubMed
    Score: 0.017
  20. Bunn PA, Ihde DC, Foon KA. The role of recombinant interferon alfa-2a in the therapy of cutaneous T-cell lymphomas. Cancer. 1986 Apr 15; 57(8 Suppl):1689-95.
    View in: PubMed
    Score: 0.016
  21. Bertness V, Kirsch I, Hollis G, Johnson B, Bunn PA. T-cell receptor gene rearrangements as clinical markers of human T-cell lymphomas. N Engl J Med. 1985 Aug 29; 313(9):534-8.
    View in: PubMed
    Score: 0.016
  22. Rosen ST, Radvany R, Roenigk H, Terasaki PI, Bunn PA. Human leukocyte antigens in cutaneous T cell lymphoma. J Am Acad Dermatol. 1985 Mar; 12(3):531-4.
    View in: PubMed
    Score: 0.015
  23. Bunn PA, Foon KA, Ihde DC, Longo DL, Eddy J, Winkler CF, Veach SR, Zeffren J, Sherwin S, Oldham R. Recombinant leukocyte A interferon: an active agent in advanced cutaneous T-cell lymphomas. Ann Intern Med. 1984 Oct; 101(4):484-7.
    View in: PubMed
    Score: 0.015
  24. Averbuch SD, Austin HA, Sherwin SA, Antonovych T, Bunn PA, Longo DL. Acute interstitial nephritis with the nephrotic syndrome following recombinant leukocyte a interferon therapy for mycosis fungoides. N Engl J Med. 1984 Jan 05; 310(1):32-5.
    View in: PubMed
    Score: 0.014
  25. Winkler CF, Bunn PA. Cutaneous T-cell lymphoma: a review. Crit Rev Oncol Hematol. 1983; 1(1):49-92.
    View in: PubMed
    Score: 0.013
  26. Brigham BA, Bunn PA, Horton JE, Schechter GP, Wahl LM, Bradley EC, Dunnick NR, Matthews MJ. Skeletal manifestations in cutaneous T-cell lymphomas. Arch Dermatol. 1982 Jul; 118(7):461-7.
    View in: PubMed
    Score: 0.012
  27. Haynes BF, Bunn P, Mann D, Thomas C, Eisenbarth GS, Minna J, Fauci AS. Cell surface differentiation antigens of the malignant T cell in Sezary syndrome and mycosis fungoides. J Clin Invest. 1981 Feb; 67(2):523-30.
    View in: PubMed
    Score: 0.011
  28. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980 Dec; 77(12):7415-9.
    View in: PubMed
    Score: 0.011
  29. Bunn PA, Huberman MS, Whang-Peng J, Schechter GP, Guccion JG, Matthews MJ, Gazdar AF, Dunnick NR, Fischmann AB, Ihde DC, Cohen MH, Fossieck B, Minna JD. Prospective staging evaluation of patients with cutaneous T-cell lymphomas. Demonstration of a high frequency of extracutaneous dissemination. Ann Intern Med. 1980 Aug; 93(2):223-30.
    View in: PubMed
    Score: 0.011
  30. Carney DN, Bunn PA. Manifestations of cutaneous T-cell lymphoma. J Dermatol Surg Oncol. 1980 May; 6(5):369-77.
    View in: PubMed
    Score: 0.011
  31. Guccion JG, Fischmann AB, Bunn PA, Schechter GP, Patterson RH, Matthews MJ. Ultrastructural appearance of cutaneous T cell lymphomas in skin, lymph nodes, and peripheral blood. Cancer Treat Rep. 1979 Apr; 63(4):565-70.
    View in: PubMed
    Score: 0.010
  32. Schechter GP, Bunn PA, Fischmann AB, Matthews MJ, Guccion J, Soehnlen F, Munson D, Minna JD. Blood and lymph node T lymphocytes in cutaneous T cell lymphoma: evaluation by light microscopy. Cancer Treat Rep. 1979 Apr; 63(4):571-4.
    View in: PubMed
    Score: 0.010
  33. Whang-Peng J, Bunn P, Knutsen T, Schechter GP, Gazdar AF, Matthews MJ, Minna JD. Cytogenetic abnormalities in patients with cutaneous T-cell lymphomas. Cancer Treat Rep. 1979 Apr; 63(4):575-80.
    View in: PubMed
    Score: 0.010
  34. Fischmann AB, Bunn PA, Guccion JG, Matthews MJ, Minna JD. Exposure to chemicals, physical agents, and biologic agents in mycosis fungoides and the S?zary syndrome. Cancer Treat Rep. 1979 Apr; 63(4):591-6.
    View in: PubMed
    Score: 0.010
  35. Keenan AM, Weinstein JN, Mulshine JL, Carrasquillo JA, Bunn PA, Reynolds JC, Larson SM. Immunolymphoscintigraphy in patients with lymphoma after subcutaneous injection of indium-111-labeled T101 monoclonal antibody. J Nucl Med. 1987 Jan; 28(1):42-6.
    View in: PubMed
    Score: 0.004
  36. Dodd RC, Winkler CF, Williams ME, Bunn PA, Gray TK. Calcitriol levels in hypercalcemic patients with adult T-cell lymphoma. Arch Intern Med. 1986 Oct; 146(10):1971-2.
    View in: PubMed
    Score: 0.004
  37. Munson D, Bunn PA, Schechter GP. Fc receptor-defined T-lymphocyte subpopulations in patients with cutaneous T-cell lymphoma. J Invest Dermatol. 1982 Nov; 79(5):317-21.
    View in: PubMed
    Score: 0.003
  38. Huberman MS, Bunn PA, Matthews MJ, Ihde DC, Gazdar AF, Cohen MH, Minna JD. Hepatic involvement in the cutaneous T-cell lymphomas: results of percutaneous biopsy and peritoneoscopy. Cancer. 1980 Apr 01; 45(7):1683-8.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)